tiprankstipranks
Legend Biotech Corporation (LEGN)
NASDAQ:LEGN
US Market

Legend Biotech (LEGN) Financial Statements

Compare
431 Followers

Legend Biotech Financial Overview

Legend Biotech's market cap is currently $6.44B. The company's EPS TTM is $-0.968; its P/E ratio is ―; Legend Biotech is scheduled to report earnings on March 13, 2025, and the estimated EPS forecast is $-0.21. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 627.24M$ 285.14M$ 117.00M$ 89.79M$ 75.68M
Gross Profit$ 392.66M$ 140.93M$ 51.64M$ -223.55M$ -156.48M
Operating Income$ 0.00$ -439.49M$ -455.83M$ -393.02M$ -313.35M
EBITDA$ -113.16M$ -477.87M$ -416.54M$ -392.38M$ -294.14M
Net Income$ -177.03M$ -518.25M$ -446.35M$ -386.21M$ -303.48M
Balance Sheet
Cash & Short-Term Investments$ 1.12B$ 1.31B$ 1.03B$ 882.39M$ 505.69M
Total Assets$ 1.67B$ 1.85B$ 1.33B$ 1.12B$ 721.01M
Total Debt$ 350.60M$ 328.67M$ 284.53M$ 122.97M$ 3.37M
Net Debt$ 63.85M$ -949.04M$ -501.50M$ -565.97M$ -452.32M
Total Liabilities$ 629.61M$ 597.24M$ 586.65M$ 647.16M$ 440.75M
Stockholders' Equity$ 1.04B$ 1.25B$ 744.31M$ 471.21M$ 280.25M
Cash Flow
Free Cash Flow$ -158.14M$ -416.00M$ -222.30M$ -245.58M$ -272.78M
Operating Cash Flow$ -144.03M$ -393.28M$ -200.03M$ -198.47M$ -223.00M
Investing Cash Flow$ -850.54M$ 92.79M$ -78.34M$ -194.98M$ -24.17M
Financing Cash Flow$ 5.70M$ 791.49M$ 377.98M$ 626.66M$ 618.88M
Currency in USD

Legend Biotech Earnings and Revenue History

Legend Biotech Debt to Assets

Legend Biotech Cash Flow

Legend Biotech Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis